Stock SGBCF SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Shanghai Henlius Biotech, Inc. OTC Markets

Equities

SGBCF

CNE100003N76

Market Closed - OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Shanghai Henlius Biotech, Inc. -.--% -.--%
24/05 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
24/05 Henlius' EU Marketing Application for Denosumab Biosimilar Accepted and Validated by Regulator MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SHANGHAI HENLIUS BIOTECH, INC.
Biopharmaceuticals
-.--%-.--% - - - 131.06Cr - - -
  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. SGBCF Stock
  5. Charts Shanghai Henlius Biotech, Inc.
  6. Relative Strength Chart